Covered recipient · General Payments record
NANCY COX
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$3,634.35
- Reported across 241 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $458.22 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $141.45 | 17 |
| Novo Nordisk AS | $112.21 | 7 |
| Lilly USA, LLC | $52.75 | 3 |
| Acerta Pharma LLC | $31.19 | 2 |
| Beckman Coulter, Inc. | $28.51 | 1 |
| Grifols USA, LLC | $19.47 | 1 |
| Vital Connect, Inc | $18.98 | 1 |
| Exact Sciences Corporation | $18.78 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $17.72 | 1 |
| Amgen Inc. | $17.16 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.98 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103511012 | CMS |
| ABBVIE INC. | $13.06 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103511014 | CMS |
| ABBVIE INC. | $2.13 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103511016 | CMS |
| ABBVIE INC. | $12.50 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103511018 | CMS |
| ABBVIE INC. | $1.70 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103511020 | CMS |
| ABBVIE INC. | $5.14 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103511022 | CMS |
| ABBVIE INC. | $1.10 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103511024 | CMS |
| ABBVIE INC. | $9.44 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103511026 | CMS |
| ABBVIE INC. | $17.43 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103511028 | CMS |
| ABBVIE INC. | $23.97 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103511030 | CMS |
| ABBVIE INC. | $1.08 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103511032 | CMS |
| ABBVIE INC. | $1.90 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103511034 | CMS |
| ABBVIE INC. | $9.05 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103511036 | CMS |
| ABBVIE INC. | $10.28 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103511038 | CMS |
| ABBVIE INC. | $3.64 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103511040 | CMS |
| ABBVIE INC. | $11.22 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103511042 | CMS |
| ABBVIE INC. | $3.83 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103511044 | CMS |
| Amgen Inc. | $17.16 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115534657 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.49 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104541750 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.70 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104698700 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $17.72 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086109640 | CMS |
| Beckman Coulter, Inc. | $28.51 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145197149 | CMS |
| Exact Sciences Corporation | $18.78 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114623365 | CMS |
| Grifols USA, LLC | $19.47 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124755968 | CMS |
| Lilly USA, LLC | $18.56 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135232868 | CMS |
| Lilly USA, LLC | $17.01 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135216338 | CMS |
| Lilly USA, LLC | $17.18 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135263737 | CMS |
| Novo Nordisk Inc | $15.80 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097760547 | CMS |
| Novo Nordisk Inc | $16.70 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096977445 | CMS |
| Novo Nordisk Inc | $17.30 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097415340 | CMS |
| Novo Nordisk Inc | $15.77 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097432280 | CMS |
| Novo Nordisk Inc | $15.21 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097013579 | CMS |
| Novo Nordisk Inc | $16.43 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097466145 | CMS |
| Novo Nordisk Inc | $15.00 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097450465 | CMS |
| Vital Connect, Inc | $18.98 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120137394 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.